Quick Answer
Adagio Medical Holdings, Inc. reported Operating Income of -$21.89 million for fiscal year 2025.
Adagio Medical Holdings, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$21.89M | +21.7% |
| 2023 | -$27.94M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.72M | -29.3% | -21.3% |
| June 30, 2025 | -$4.72M | +29.2% | +36.2% |
| March 31, 2025 | -$7.40M | +16.1% | -67.2% |
| September 30, 2024 | -$4.42M | +51.3% | +28.7% |
| July 31, 2024 | -$6.21M | — | +6.8% |
| June 30, 2024 | -$6.66M | — | +24.5% |
| March 31, 2024 | -$8.81M | — | +2.9% |
| September 30, 2023 | -$9.08M | — | — |
- Adagio Medical Holdings, Inc. showed an increase of +21.7% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Adagio Medical Holdings, Inc.’s operating income has grown by 21.7% (from -$27.94 million to -$21.89 million).
- The most recent figure is from Adagio Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: